Elon Musk’s Neuralink Secures FDA Approval for Groundbreaking Implant to Restore Vision, Even for Those Born Blind
On September 17, 2024, Neuralink, the brain-chip company founded by Elon Musk, achieved a remarkable milestone. The U.S. Food and Drug Administration (FDA) granted its experimental vision-restoring implant, known as ‘Blindsight,’ the prestigious “breakthrough device” designation. This designation is reserved for medical devices that could offer significant advancements in treating serious or life-threatening conditions, and […]